• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510600
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Spasm(s) (1966); Neuropathy (1983); Pain (1994); Weakness (2145); Tingling (2171); Numbness (2415); Ambulation Difficulties (2544)
Event Type  Injury  
Manufacturer Narrative
Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on (b)(6) 2008 the patient was pre-operatively diagnosed with 1.Lumbar spondylosis.2.Lumbar spinal stenosis.3.Neurogenic claudication and underwent the following procedures: 1.Posterior spinal fusion from l3 to s1.2.Posterior segmental spinal instrumentation from l3 to s1 utilizing the 5.5 mm stainless steel system.3.Laminectomy, bilateral partial medial facetectomies, and bilateral foraminotomies from l3 to ls.4.Augmentation of posterior spinal fusion with morselized local bone graft (40 ml).5.Augmentation of posterior spinal fusion with demineralized bone matrix (10 ml putty).6.Augmentation of posterior spinal fusion with rhbmp-2 (48 mg of rhbmp-2 on 20 ml graft matrix with 2.4 mg/ml graft volume concentration).7.Application of gardner-wells tongs for temporary intraoperative tr action.8.Spinal cord monitoring consisting of somatosensory evoked potentials and electromyography.As per the op notes: ¿at this point, we turned our attention to decorticating the spine.We paid particular attention to decorticating the facet joints bilaterally.We also decorticated the remaining posterior elements including all transverse processes and the sacral ala.Once the spine was thoroughly decorticated, we placed 48 mg of rhbmp-2 on 20 ml graft matrix 2.4 mg/ml graft volume concentration into decorticated facet joints and over the decorticated posterior elements.This was then followed by 40 ml morselized local bone graft mixed with 10 ml putty.¿ post-op, patient reportedly had "progressively worsening and extreme lower back pain and stiffness, radiating pain into his buttocks and down his legs, severe right hip pain, and constant numbness/tingling in his right hip and legs"."severe pain and symptoms ultimately compelled patient to undergo a revision surgery on (b)(6) 2016.Despite revision surgery, patient continues to experience low back pain and occasional muscle spasms, stiffness in his upper back, numbness in his upper right hip and left leg, and weakness in his right leg.He experiences difficulty sitting, standing and walking, and wears a back brace daily.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea road
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea road
memphis TN 38118
Manufacturer Contact
stacie ziemba
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6897723
MDR Text Key87514197
Report Number1030489-2017-02123
Device Sequence Number1
Product Code NEK
UDI-Device Identifier00681490843812
UDI-Public00681490843812
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial
Report Date 09/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2010
Device Catalogue Number7510600
Device Lot NumberM110610AAA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/05/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/03/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-